David R. Powell

Lrp5 functions in bone to regulate bone mass

Yajun Cui, Paul Niziolek, Bryan T. MacDonald et al. · Nature Medicine · 2011 · 444 citations · Full text

Mechanobiology, Signal Transduction, Bone Morphogenic Protein +8

Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia

Timo Rieg, Takahiro Masuda, Maria Gerasimova et al. · American Journal of Physiology-Renal Physiology · 2013 · 296 citations · Full text

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial

Brian Zambrowicz, J Freiman, Phil Brown et al. · Clinical Pharmacology & Therapeutics · 2012 · 235 citations · Full text

KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation

Laura R. Pearce, Neli Atanassova, Matthew C. Banton et al. · Cell · 2013 · 195 citations · Full text

LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose

David R. Powell, Melinda Smith, Jennifer Greer et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 181 citations